Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsClosing the COVID-19 Prevention Gap This Flu Season, With Juanita Mora, MD
Darren Gitelman, MD, senior medical director of the Advocate Memory Center in Park Ridge, discusses findings linking high-dose influenza vaccination to lower Alzheimer disease risk, study limitations, and potential implications for future dementia prevention research.
Postmarketing reports of product-related insertional oncogenesis involving GLI1 have prompted an FDA investigation into malignancy risk with SMA gene therapy, onasemnogene abeparvovec.
1.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
2.
Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?
3.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
4.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
5.
Promising for Monitoring and Diagnosis of AD is the finger-prick test.
1.
Comprehensive Techniques in Hematology in Clinical Decision-Making
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
4.
Risk Assessment of Iron Overload in Repeated Transfusion
5.
Epigenetic Signatures for Multi-Cancer Screening
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
Predicting Delayed Hemolytic Transfusion Reactions Through Donor-Recipient Antigen Exposure Modeling
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge